WHO/Europe is working with immunization programmes across the European Region to help them raise awareness about HPV vaccination, address obstacles to high uptake and prepare for HPV vaccine introduction where it is not yet part of the routine immunization programme. As part of this work WHO/Europe has led or collaborated in the production of information materials, including the following resources: Video: HPV and cervical cancer – a personal story Video: How the HPV vaccine works ...

HLN today released a new version of its ICE Open Source Immunization Evaluation and Forecasting software covering the following changes: HPV updates: (1) Added support for new 2-dose series; recommend based on 2- or 3-dose series accordingly. (2) Ignore (HPV, bivalent (Cervarix)) shots administered to males. (3) Removed minimum age restriction for dose 2 and dose 3 Meningococcal updates: (1) Added absolute minimum age/minimum age of 16 years for dose 2. (2) Changed recommended interval be...

The Indian government suspended research in April 2010 on the feasibility and safety of human papillomavirus (HPV) vaccine in two Indian states (Andhra Pradesh and Gujarat) amid public concerns about its safety. This paper describes cervical cancer and cancer surveillance in India and reviews the epidemiological claims made by the Programme for Appropriate Technology in Health (PATH) in support of the vaccine in these two states. National cancer data published by the Indian National Cancer Regis...

In collaboration with Merck & Co., Inc. and GSK, PATH Seattle has prepared a list of countries where each of these company's vaccines is licensed and a world map showing the countries where one of the vaccines is licensed for use and the countries where both vaccines are licensed for use. These two documents can be seen on TechNet21 website: Global HPV vaccine licensure status: June 2011 Map: Global HPV vaccine licensure status June 2011 Licensure, of course, does not mean that the vaccine in i...

This message has been cross-posted from HPV Vaccine Global Community of Practice. With many thanks to Robert Steinglass. Dear Lisa, I agree with Sarah Mullins that there is a great opportunity to find links with a larger package of interventions, including tetanus vaccination. The following four resources provide some relevant background information. a) To read about school-based immunization experiences, much of which has been based on administration of tetanus toxoid, documented from Indone...